Vesicular ATP-binding cassette transporters in human disease: relevant aspects of their organization for future drug development

[1]  J. Kowal,et al.  Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1 , 2020, Proceedings of the National Academy of Sciences.

[2]  G. Bendas,et al.  Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-spectrum ABCB1, ABCC1, and ABCG2 Antagonists. , 2020, Journal of medicinal chemistry.

[3]  Jürgen Bajorath,et al.  Compounds with multitarget activity: structure-based analysis and machine learning , 2020 .

[4]  C. Kuntner,et al.  Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomography , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  D. Sviridov,et al.  Lipid rafts as a therapeutic target , 2020, Journal of Lipid Research.

[6]  D. Richardson,et al.  The growing evidence for targeting P-glycoprotein in lysosomes to overcome resistance. , 2020, Future Medicinal Chemistry.

[7]  D. Klionsky,et al.  Autophagy and disease: unanswered questions , 2020, Cell Death & Differentiation.

[8]  Allen F. Brooks,et al.  Evaluation of [18F]N-methyl-lansoprazole as a tau PET imaging agent in first-in-human studies. , 2020, ACS chemical neuroscience.

[9]  O. Langer,et al.  Imaging P-Glycoprotein Induction at the Blood–Brain Barrier of a β-Amyloidosis Mouse Model with 11C-Metoclopramide PET , 2019, The Journal of Nuclear Medicine.

[10]  M. Wiese,et al.  The A‐B‐C of small‐molecule ABC transport protein modulators: From inhibition to activation—a case study of multidrug resistance‐associated protein 1 (ABCC1) , 2019, Medicinal research reviews.

[11]  S. Stefan.  Multi-target ABC transporter modulators: what next and where to go? , 2019, Future medicinal chemistry.

[12]  Katherine M. Rentschler,et al.  The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive Impairment , 2019, International journal of molecular sciences.

[13]  V. Namasivayam,et al.  Identification of Thienopyrimidine Scaffold as an Inhibitor of the ABC Transport Protein ABCC1 (MRP1) and Related Transporters Using a Combined Virtual Screening Approach. , 2019, Journal of medicinal chemistry.

[14]  S. Sarfare,et al.  Expression of ABCA4 in the retinal pigment epithelium and its implications for Stargardt macular degeneration , 2018, Proceedings of the National Academy of Sciences.

[15]  O. Langer,et al.  Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  W. Löscher,et al.  Mechanism of drug extrusion by brain endothelial cells via lysosomal drug trapping and disposal by neutrophils , 2018, Proceedings of the National Academy of Sciences.

[17]  C. Kuntner,et al.  Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[11C]Methylpurine in Mice , 2018, Molecular Imaging and Biology.

[18]  M. Wiese,et al.  Small‐molecule inhibitors of multidrug resistance‐associated protein 1 and related processes: A historic approach and recent advances , 2018, Medicinal research reviews.

[19]  A. Castle,et al.  Reinterpretation of the localization of the ATP binding cassette transporter ABCG1 in insulin-secreting cells and insights regarding its trafficking and function , 2018, bioRxiv.

[20]  J. Kowal,et al.  Structural basis of small-molecule inhibition of human multidrug transporter ABCG2 , 2018, Nature Structural & Molecular Biology.

[21]  D. Richardson,et al.  Tumor stressors induce two mechanisms of intracellular P-glycoprotein–mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones , 2018, The Journal of Biological Chemistry.

[22]  J. Wiltfang,et al.  ABC Transporters Are Key Players in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[23]  J. Dogné,et al.  Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo. , 2017, Leukemia research.

[24]  M. Wiese,et al.  9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein. , 2017, Journal of medicinal chemistry.

[25]  X. Gong,et al.  Structure of the Human Lipid Exporter ABCA1 , 2017, Cell.

[26]  Silva Hecimovic,et al.  Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins , 2016, PloS one.

[27]  Giuseppe Agapito,et al.  Genetic variants associated with gastrointestinal symptoms in Fabry disease , 2016, Oncotarget.

[28]  Shufeng Zhou,et al.  Molecular mechanisms for tumour resistance to chemotherapy , 2016, Clinical and experimental pharmacology & physiology.

[29]  M. Morita,et al.  Translocation of the ABC transporter ABCD4 from the endoplasmic reticulum to lysosomes requires the escort protein LMBD1 , 2016, Scientific Reports.

[30]  L. Lannfelt,et al.  Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons , 2016, Molecular Neurodegeneration.

[31]  Hongyun Li,et al.  Understanding the function of ABCA7 in Alzheimer's disease. , 2015, Biochemical Society transactions.

[32]  N. Caberoy,et al.  ABCF1 extrinsically regulates retinal pigment epithelial cell phagocytosis , 2015, Molecular biology of the cell.

[33]  G. Szakács,et al.  Role of the N-terminal transmembrane domain in the endo-lysosomal targeting and function of the human ABCB6 protein , 2015, The Biochemical journal.

[34]  I. Hamza,et al.  Control of metazoan heme homeostasis by a conserved multidrug resistance protein. , 2014, Cell metabolism.

[35]  T. Drake,et al.  ABCC6 Localizes to the Mitochondria-Associated Membrane , 2012, Circulation research.

[36]  G. Szakács,et al.  Shifting the Paradigm: The Putative Mitochondrial Protein ABCB6 Resides in the Lysosomes of Cells and in the Plasma Membrane of Erythrocytes , 2012, PloS one.

[37]  Y. Sugiyama,et al.  Sorting Nexin 27 Interacts with Multidrug Resistance-associated Protein 4 (MRP4) and Mediates Internalization of MRP4* , 2012, The Journal of Biological Chemistry.

[38]  P. Edwards,et al.  ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter , 2011, Proceedings of the National Academy of Sciences.

[39]  M. Oppermann,et al.  Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3 , 2011, Proceedings of the National Academy of Sciences.

[40]  J. A. Maguire,et al.  A novel conserved targeting motif found in ABCA transporters mediates trafficking to early post-Golgi compartments[S] , 2011, Journal of Lipid Research.

[41]  Hiroshi Suzuki,et al.  NPC2 regulates biliary cholesterol secretion via stimulation of ABCG5/G8-mediated cholesterol transport. , 2011, Gastroenterology.

[42]  Du Feng,et al.  Membrane localization of beta-amyloid 1-42 in lysosomes: a possible mechanism for lysosome labilization. , 2010, The Journal of biological chemistry.

[43]  L. Walker,et al.  Alzheimer's disease and blood–brain barrier function—Why have anti-β-amyloid therapies failed to prevent dementia progression? , 2009, Neuroscience & Biobehavioral Reviews.

[44]  D. Butterfield,et al.  Mrp1 Localization and Function in Cardiac Mitochondria after Doxorubicin , 2009, Molecular Pharmacology.

[45]  O. Wolkenhauer,et al.  Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's disease. , 2008, Current Alzheimer research.

[46]  N. Cheong,et al.  Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration , 2008, Leukemia.

[47]  Paul T. Tarr,et al.  ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2 Published, JLR Papers in Press, October 4, 2007. , 2008, Journal of Lipid Research.

[48]  R. Tampé,et al.  Intracellular peptide transporters in human – compartmentalization of the “peptidome” , 2007, Pflügers Archiv - European Journal of Physiology.

[49]  P. Milkiewicz,et al.  Oxidative stress induces internalization of the bile salt export pump, Bsep, and bile salt secretory failure in isolated rat hepatocyte couplets: a role for protein kinase C and prevention by protein kinase A. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[50]  Y. Assaraf,et al.  Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance. , 2005, Cancer research.

[51]  Yoshiyuki Kubo,et al.  ABCA5 Resides in Lysosomes, and ABCA5 Knockout Mice Develop Lysosomal Disease-Like Symptoms , 2005, Molecular and Cellular Biology.

[52]  E. Favari,et al.  Probucol Inhibits ABCA1-Mediated Cellular Lipid Efflux , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[53]  T. Kirchhausen,et al.  Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide Published, JLR Papers in Press, April 21, 2004. DOI 10.1194/jlr.M300358-JLR200 , 2004, Journal of Lipid Research.

[54]  S. Bates,et al.  Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2* , 2004, Journal of Biological Chemistry.

[55]  H. Kroemer,et al.  The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease. , 2004, Current Alzheimer research.

[56]  S. Simon,et al.  Subcellular localization and activity of multidrug resistance proteins. , 2003, Molecular biology of the cell.

[57]  Christiane Kunert-Keil,et al.  Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. , 2002, Pharmacogenetics.

[58]  U. Quast,et al.  Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits. , 2002, Molecular pharmacology.

[59]  A. Holzenburg,et al.  The Structure of the Multidrug Resistance Protein 1 (MRP1/ABCC1) , 2001, The Journal of Biological Chemistry.

[60]  V. Ling,et al.  Detection of oligomeric and monomeric forms of P-glycoprotein in multidrug resistant cells. , 1994, Biochemistry.

[61]  M. Wiese,et al.  Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1). , 2017, Biochimica et biophysica acta. Biomembranes.

[62]  K. Hadjiolova,et al.  Endosomal KATP channels as a reservoir after myocardial ischemia: a role for SUR2 subunits. , 2011, American journal of physiology. Heart and circulatory physiology.